These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

219 related items for PubMed ID: 14764642

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Determination of five abused drugs in nitrite-adulterated urine by immunoassays and gas chromatography-mass spectrometry.
    Tsai SC, ElSohly MA, Dubrovsky T, Twarowska B, Towt J, Salamone SJ.
    J Anal Toxicol; 1998 Oct; 22(6):474-80. PubMed ID: 9788522
    [Abstract] [Full Text] [Related]

  • 3. Comparison of the Microgenics CEDIA heroin metabolite (6-AM) and the Roche Abuscreen ONLINE opiate immunoassays for the detection of heroin use in forensic urine samples.
    Holler JM, Bosy TZ, Klette KL, Wiegand R, Jemionek J, Jacobs A.
    J Anal Toxicol; 2004 Sep; 28(6):489-93. PubMed ID: 15516301
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. ONTRAK TESTCUP: a novel, on-site, multi-analyte screen for the detection of abused drugs.
    Towt J, Tsai SC, Hernandez MR, Klimov AD, Kravec CV, Rouse SL, Subuhi HS, Twarowska B, Salamone SJ.
    J Anal Toxicol; 1995 Oct; 19(6):504-10. PubMed ID: 8926746
    [Abstract] [Full Text] [Related]

  • 6. Immunoassay and GC-MS procedures for the analysis of drugs of abuse in meconium.
    ElSohly MA, Stanford DF, Murphy TP, Lester BM, Wright LL, Smeriglio VL, Verter J, Bauer CR, Shankaran S, Bada HS, Walls HC.
    J Anal Toxicol; 1999 Oct; 23(6):436-45. PubMed ID: 10517548
    [Abstract] [Full Text] [Related]

  • 7. Oral fluid testing for drugs of abuse: positive prevalence rates by Intercept immunoassay screening and GC-MS-MS confirmation and suggested cutoff concentrations.
    Cone EJ, Presley L, Lehrer M, Seiter W, Smith M, Kardos KW, Fritch D, Salamone S, Niedbala RS.
    J Anal Toxicol; 2002 Oct; 26(8):541-6. PubMed ID: 12501910
    [Abstract] [Full Text] [Related]

  • 8. Optimization of cloned enzyme donor immunoassay cut-offs for drugs of abuse in whole blood of drivers involved in road accidents.
    Pelletti G, Garagnani M, Rossi F, Roffi R, Barone R, Pelotti S.
    Forensic Sci Int; 2019 Jan; 294():27-33. PubMed ID: 30447484
    [Abstract] [Full Text] [Related]

  • 9. The analytical performance of six urine drug screens on cobas 6000 and ARCHITECT i2000 compared to LC-MS/MS gold standard.
    Abou El Hassan M, Colantonio D, Likhodii S, Nassar BA.
    Clin Biochem; 2021 Jul; 93():99-103. PubMed ID: 33844982
    [Abstract] [Full Text] [Related]

  • 10. Papain: a novel urine adulterant.
    Burrows DL, Nicolaides A, Rice PJ, Dufforc M, Johnson DA, Ferslew KE.
    J Anal Toxicol; 2005 Jul; 29(5):275-95. PubMed ID: 16105251
    [Abstract] [Full Text] [Related]

  • 11. Optimization and validation of CEDIA drugs of abuse immunoassay tests in serum on Hitachi 912.
    Kirschbaum KM, Musshoff F, Schmithausen R, Stockhausen S, Madea B.
    Forensic Sci Int; 2011 Oct 10; 212(1-3):252-5. PubMed ID: 21775079
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Cozart RapiScan Oral Fluid Drug Testing System: an evaluation of sensitivity, specificity, and efficiency for cocaine detection compared with ELISA and GC-MS following controlled cocaine administration.
    Kolbrich EA, Kim I, Barnes AJ, Moolchan ET, Wilson L, Cooper GA, Reid C, Baldwin D, Hand CW, Huestis MA.
    J Anal Toxicol; 2003 Oct 10; 27(7):407-11. PubMed ID: 14606993
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Performance of immunoassays in screening for opiates, cannabinoids and amphetamines in post-mortem blood.
    Hino Y, Ojanperä I, Rasanen I, Vuori E.
    Forensic Sci Int; 2003 Jan 28; 131(2-3):148-55. PubMed ID: 12590054
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.